G3 (Triple Agonist) (10mg)
$180.00
G3 is an investigational triple agonist that activates GLP-1, GIP, and glucagon receptors. Technical data suggests this compound facilitates research into enhanced energy expenditure pathways and metabolic refinement. It is currently utilized for comparative studies regarding multi-receptor activation.
Availability: In Stock
Description
Description
G3 (Triple Agonist)
10MG RESEARCH UNIT
TARGET: GLP-1 / GIP / GLUCAGON
CAS: Investigational
✓ PURITY VERIFIED ≥ 99%
| Unit Size | 10mg Lyophilized Powder |
|---|---|
| Mechanism Type | Multi-Receptor Incretin Agonist |
| Research Focus | Energy Expenditure & Metabolic Homeostasis |
| Biological Class | Triple Agonist Peptide |
Scientific Research Monographs // Educational Use Only
Multi-Pathway Metabolic Refinement
Scientific Findings
G3 facilitates simultaneous activation of GLP-1, GIP, and glucagon receptors. Technical data suggest this triple agonism promotes thermogenesis and enhanced energy expenditure while modulating glucose-dependent insulin secretion. Glucagon receptor activation, in particular, is researched for its ability to increase lipid oxidation.
Plain English Interpretation
G3 acts like a "master key" for metabolic health. Instead of turning on just one signal, it activates three different pathways at once to help the body use energy more efficiently, manage sugar levels, and increase the rate at which it burns fat.
Comparative Research Context
Scientific Findings
Current research utilizes G3 for comparative studies against dual-agonists (GLP-1/GIP) to determine the added metabolic benefit of glucagon receptor engagement. Laboratory observations focus on the synergistic effects of triple-receptor signaling on adipose tissue remodeling.
Plain English Interpretation
Scientists are using G3 to see if adding a third signal makes a bigger difference than the two signals found in older versions. They are specifically looking at how this combination changes how fat is stored and used in the body.
RESEARCH NOTICE: For laboratory research and development only. Not for human consumption. Reference: AP-G3-10-2026.
Reviews (0)
Storage Details
Stability & Storage Protocol
DOC ID: AP-STB-2026
Advanced Lyophilization Process
At Accel Peptides, we partner with manufacturing facilities specializing in Lyophilization (freeze-drying). This advanced process ensures compounds remain stable during transit and storage for over 12 months.When kept in their freeze-dried state, these compounds stay effective for extended periods. For long-term preservation, we recommend storing them in the freezer to maintain maximum molecular integrity.
FDA Standard Requirement
The common "discard 28 days after first use" guideline is a standard requirement set for multi-use vials to confirm bacteriostatic water retains its preservative qualities.
Accel Empirical Experience
With strict sterile handling and refrigeration, a reconstituted vial can safely remain stable and effective for three months or longer.
*Stability is dependent on sterile technique and consistent temperature control.
Certificates of Analysis
13 Peptide COAs
Avg purity —%
Lab: Freedom Diagnostics
| Peptide / Blend | Batch / Product Lot | Accession No. | Reported Date | Purity (HPLC-MS) | Laboratory | Certificate |
|---|
Related products
$149.00 — or Original price was: $149.00.$119.20Current price is: $119.20. / month
Reviews
There are no reviews yet.